Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19525
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSiamopoulos, K. C.en
dc.contributor.authorEleftheriades, E. G.en
dc.contributor.authorPappas, M.en
dc.contributor.authorSferopoulos, G.en
dc.contributor.authorTsolas, O.en
dc.date.accessioned2015-11-24T19:00:23Z-
dc.date.available2015-11-24T19:00:23Z-
dc.identifier.issn0301-0163-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19525-
dc.rightsDefault Licence-
dc.subjectAdrenocorticotropic Hormone/*blooden
dc.subjectAdulten
dc.subjectCorticotropin-Releasing Hormone/*diagnostic use/pharmacokinetics/pharmacologyen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectHydrocortisone/*blooden
dc.subjectHypothalamo-Hypophyseal System/*physiopathologyen
dc.subjectKidney Failure, Chronic/blood/*physiopathology/therapyen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectPituitary-Adrenal System/*physiopathologyen
dc.subjectRenal Dialysisen
dc.titleOvine corticotropin-releasing hormone stimulation test in patients with chronic renal failure: pharmacokinetic properties, and plasma adrenocorticotropic hormone and serum cortisol responsesen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/2851525-
heal.identifier.secondaryhttp://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000181019-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate1988-
heal.abstractThe data on the status of the hypothalamic-pituitary-adrenal (HPA) axis in haemodialysis (HD) patients are conflicting. Moreover, a state reminiscent of Cushing's syndrome has been reported in this group of patients. Corticotropin-releasing hormone (CRH), that is produced by the hypothalamus and modulates the secretion of adrenocorticotropic hormone (ACTH), has been shown to be useful as a provocative test of the HPA axis. We investigated the effect of exogenous ovine CRH (oCRH) on plasma levels of ACTH and cortisol in 13 chronic HD patients. The plasma concentrations of immunoreactive CRH following oCRH administration were similar in patients and controls. In all patients, oCRH given intravenously as bolus injection caused a further increase in the already elevated levels of cortisol. The mean basal plasma levels of ACTH were within the normal range. There was, however, a blunted ACTH response to oCRH. We conclude that the HPA axis in chronic HD patients retains the ability to respond to exogenous oCRH. The patterns of the ACTH and cortisol response to this peptide resemble those observed in chronic stress (depression, anorexia nervosa). Besides, the kinetics of disappearance of oCRH indicate that the kidney may not be the major organ that metabolizes oCRH.en
heal.journalNameHorm Resen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons